Contributing Experts

April 25, 2012

Nils Cordes, M.D.


Professor Nils Cordes was born in 1968 in Bremen, Germany. In 2003, he started his studies in Medicine at the University of Erlangen-Nürnberg, Germany. First contact with radiobiology was in 2004 in the context of the experiments for his M.D. thesis on the effects of the chemotherapeutic drug Taxol in combination with radiotherapy.

After finishing his studies, Dr. Cordes was trained as radiation oncologist for some years until he decided to get into science fulltime. The main topic was always tumor cell resistance to therapy. Building up a research group at the Institute of Radiobiology of the Germany Armed Forces enabled him to accelerate the gain of knowledge on integrins and how they influence tumor cell resistance to therapy. In 2005, Dr. Cordes was appointed as young research group leader for “Biological and Molecular Targeting” at OncoRay, Medical Faculty Carl Gustav Carus, Dresden University of Technology, Dresden, Germany. Currently, he is Professor of Molecular and Cellular Radiobiology, Head of Radiobiology and group leader of “Molecular and Cellular Radiobiology” at OncoRay, which has been nominated as National Center for Radiation Research in Oncology in 2010.

Last Updated: November 4, 2014

Sign up for

My RxWiki  &   RxWiki Notify

Follow the medications that matter most to
you and Ask related questions.

Receive email notifications as soon as your
medication pages are updated.

Nils Cordes, M.D. Insights